Brind.

Sam Raha highlighted operational execution and workflow improvements at Myriad Genetics on August 13, 2025.

2 reports, 1 independent Updated Aug 13

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sam Raha highlighted operational execution and workflow improvements at Myriad Genetics on August 13, 2025.

Who's involved

What this event is mainly about

Myriad Genetics

Keep exploring

The entities involved

Myriad Genetics
American biotechnology company
- MarketBeat is reporting on analyst recommendations and consensus target prices for small-cap healthcare companies Myriad Genetics and Applied DNA Sciences.Fri 11:44

Coverage

Newest first; wire copies grouped

Aug 13StockStoryMYGN Q2 Deep Dive: Oncology Strategy Shift and Product Execution Shape Guidance Genetic testing company Myriad Genetics (NASDAQ:MYGN) reported Q2 CY2025 results beating Wall Street’s revenue expectat
Aug 6StockStoryMyriad Genetics (NASDAQ:MYGN) Reports Strong Q2, Stock Jumps 30.6% Genetic testing company Myriad Genetics (NASDAQ:MYGN) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales w